Beijing Aosaikang Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -19.09% vs -14.51% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -89.87% vs -37.55% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "345.10",
          "val2": "426.50",
          "chgp": "-19.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "59.60",
          "val2": "79.90",
          "chgp": "-25.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.20",
          "chgp": "-50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.10",
          "val2": "3.70",
          "chgp": "-16.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6.10",
          "val2": "60.20",
          "chgp": "-89.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "72.40%",
          "val2": "106.10%",
          "chgp": "-3.37%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -0.10% vs 23.08% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 66.30% vs 161.93% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,757.70",
          "val2": "1,759.50",
          "chgp": "-0.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "327.60",
          "val2": "185.00",
          "chgp": "77.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.20",
          "val2": "3.00",
          "chgp": "-60.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "14.60",
          "val2": "12.70",
          "chgp": "14.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "213.70",
          "val2": "128.50",
          "chgp": "66.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "110.20%",
          "val2": "52.80%",
          "chgp": "5.74%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

345.10

426.50

-19.09%

Operating Profit (PBDIT) excl Other Income

59.60

79.90

-25.41%

Interest

0.10

0.20

-50.00%

Exceptional Items

3.10

3.70

-16.22%

Consolidate Net Profit

6.10

60.20

-89.87%

Operating Profit Margin (Excl OI)

72.40%

106.10%

-3.37%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is -19.09% vs -14.51% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -89.87% vs -37.55% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,757.70

1,759.50

-0.10%

Operating Profit (PBDIT) excl Other Income

327.60

185.00

77.08%

Interest

1.20

3.00

-60.00%

Exceptional Items

14.60

12.70

14.96%

Consolidate Net Profit

213.70

128.50

66.30%

Operating Profit Margin (Excl OI)

110.20%

52.80%

5.74%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -0.10% vs 23.08% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 66.30% vs 161.93% in Dec 2024

All Annual Results